[Activity of a new derivative of 3-hydrazinopyridazine: ISF 2123 in patients with hypertension. I].
D000368:Aged; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D006834:Hydrazines / Q000008:administration & dosage / Q000627:therapeutic use; D006973:Hypertension / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D011412:Propanolamines / Q000008:administration & dosage / Q000627:therapeutic use; D011724:Pyridazines / Q000008:administration & dosage / Q000627:therapeutic use*
D006834:Hydrazines; D011412:Propanolamines; D011724:Pyridazines; C009978:propildazine
Attività di un nuovo derivato della 3-idrazinopiridazina: ISF 2123 in pazienti ipertesi. Nota I